FDA NDC Directory · JSON-LD · Markdown

Insulin glargine U-300 Max

NDC 0955-2900 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameinsulin glargine
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA206538
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsINSULIN GLARGINE (300 [iU]/mL)
Marketing started20230401
Package count1

External sources

Source: openFDA. Public-domain (CC0).